Movement Disorders Program

Movement Disorders Program

Dr. Ebrahimi-Fakhari directs the Movement Disorders Program at Boston Children’s Hospital. The team at the Movement Disorders Program provides specialty care for infants, children, and adolescents with genetic and acquired movement disorders. The team includes neurologists with special training in movement disorders, genetic counselors, physical and occupational therapists, and social workers. We work together to develop a treatment plan that meets every child’s unique needs and maximizes quality of life.

The treatment portfolio also includes specialized procedures, such as the treatment of spasticity and dystonia with botulinum toxin injections, and the treatment of dystonia and other hyperkinetic movement disorders with Deep Brain Stimulation (DBS). As part of our commitment to advancing DBS treatment globally, we have made DBSMatchMaker – a collaborative platform connecting clinicians to share expertise in treating pediatric movement disorder with DBS.

Specialists in the Movement Disorders Program lead several research programs and clinical trials that work synergistically with our clinical care. We collaborate closely with clinicians and researchers across North America and internationally.

Pediatric Movement Disorders & Neurogenetics Fellowship



The Movement Disorders Program at Boston Children’s Hospital offers a unique clinical fellowship in Pediatric Movement Disorders & Neurogenetics The goal of this clinical training program is to provide fellows with the skills to become experts in the diagnosis and treatment of pediatric movement disorders, with a particular focus on genetic movement disorders. The core component of the clinical education consists of evaluating patients in the Boston Children’s Hospital Movement Disorders Program and select clinics within the Movement Disorders Divisions at Massachusetts General Hospital and Beth Israel Deaconess Medical Center. Clinical activities are overseen by faculty with sub-specialty training in movement disorders. The program also includes training in neurogenetics, rare disease research, precision medicine approaches, and specialized techniques and procedures for movement disorders, such as deep brain stimulation and botulinum toxin injections.

We hope to train the next generation of physician-scientists in cutting edge clinical care, translational research and hope for our fellows to become leaders in the field of pediatric movement disorders.

Current Fellows

null

Monica Ferrer Socorro, M.D.

Clinical Fellow, Movement Disorders Program, Class of 2026

Residency
Child Neurology 2025
NYU Grossman School of Medicine

null

Rebecca Lindsay, M.D.

Clinical Fellow, Movement Disorders Program, Class of 2027 (incoming fellow)

Residency
Child Neurology 2026
Alberta Children’s Hospital, University of Calgary

Alumni

null

Vicente Quiroz, M.D.

Clinical Fellow, Movement Disorders Program, Class of 2024

Residency
Pediatric Neurology 2021
University of Valparaiso, Valparaiso, Chile

null

Kathryn Yang, MBChB, FRCPC

Clinical Fellow, Movement Disorders Program, Class of 2025

Residency
Pediatric Neurology 2023
The Hospital for Sick Children, Toronto, CA

null

Zainab Zaman, MBBS

Clinical Fellow, Movement Disorders Program, Class of 2026

Residency
Child Neurology and Neurodevelopmental Disabilities 2024
Boston Children’s Hospital

For more information on applying to our fellowship program, please visit BCH’s Clinical Fellowship in Pediatric Movement Disorders & Neurogenetics page.

Educational Resources

Elective Rotations in Our Movement Disorders Program

Our program offers a limited number of short-term elective rotations to child neurology trainees, movement disorders fellows, and faculty from the United States and abroad. Rotations vary in duration and follow a structured didactic curriculum. Participants have the status of Observers and are registered with the Graduate Medical Education (GME) Office and the Department of Neurology at Boston Children’s Hospital.

All rotations are contingent upon securing sufficient self-funding and meeting the requirements for clinical observers at Boston Children’s Hospital, including completion of occupational health screening.

For inquiries about elective rotations with our program, please contact: movement.disorders@childrens.harvard.edu.
Alumni from our elective rotation program are listed below:

YearName - Institution
2026Ludmila Novotna, MD; 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
2026Francesca Maria Agostina Papoff, MD; IRCCS Fondazione Stella Maris, Italy
2025Giovana Ribeiro, MD; UNICAMP, Campinas, Brazil
2025Nina Wilpert, MD, PhD; Berlin Charité, Germany
2025Paulo Cataniag, MD; Makati Medical Center, Phillipines
2025Veronica Altamiro, MD; University of Iowa, IA
2025Asif Doja, MD; Children’s Hospital of Eastern Ontario, Canada
2025Dimitrios I Zafeiriou, MD, PhD; Aristotle University of Thessaloniki, Greece
2024Lindsey Vogt, MD; The Hospital for Sick Children, University of Toronto, Canada
2024Dakota Peacock, MD; University of British Columbia, Canada
2024Rebecca Lindsay, MD; University of Alberta, Canada
2024Alexandra Lewinsky DeArias, DO; Yale School of Medicine, CT

MDS-PAS Pediatric Movement Disorders Conference

The field of Pediatric Movement Disorders is advancing rapidly, driven by significant breakthroughs in genomics, gene therapy, and neuromodulation. These developments present unparalleled opportunities to enhance care for children affected by movement disorders. The first MDS-PAS Pediatric Movement Disorders Course will provide a state-of-the-art review of current practices, controversies, and active areas of research in pediatric movement disorders.

https://education.movementdisorders.org/Detail/909/MDS-PAS-Pediatric-Movement-Disorders-Conference

PASPEDS_1920x1005 (1)

Multi-Institutional Pediatric Movement Seminar Series 2026-2027

This seminar series is organized between the Pediatric Movement Disorders Programs at Boston
Children’s Hospital in Boston, the Hospital for Sick Children in Toronto, Children’s National Medical Center
in Washington, D.C., Children’s Hospital of Philadelphia, and University of Rochester Medical Center.

DateSpeakerTopic
9/24/26Darius Ebrahimi-Fakhari, MD, PhD (BCH)Introduction to the classification and phenomenology of childhood-onset movement disorders
10/1/26Laura Tochen, MD (Children’s National)Introduction to symptomatic management of childhood-onset movement disorders
10/22/26Carolina Gorodetsky, MD (SickKids)Introduction to deep brain stimulation
10/29/26Angela Hewitt, MD (University of Rochester)Approach to childhood-onset dystonia
11/5/26Mohammed AlQahtani, MD (BCH Fellow)Fellow case presentation
11/12/26Asif Doja, MD (Children’s Hospital of Eastern Ontario)Transient and developmental movement disorders
11/19/26Alexander Munchau, MD (Universität zu Lübeck)An overview of the paroxysmal dyskinesias
12/3/26Ruba Alayed, MD (SickKids Fellow)Fellow case presentation
12/10/26Kinga Tomczak, MD (BCH)Evaluation and treatment of tics and Tourette syndrome
12/17/26Kathryn Yang, MD (BCH)Movement disorder emergencies
1/7/27Angela Hewitt, MD (University of Rochester)Case presentation
1/14/27Darius Ebrahimi-Fakhari, MD, PhD (BCH)Neuroimaging in movement disorders
1/21/27Katerina Bernardi, MD (BCH)Overview of epilepsy-dyskinesia syndromes
1/28/27Speaker TBD (CHOP)Fellow case presentation
2/4/27Alonso Zea Vera, MD (CHOP)Approach to childhood-onset ataxia
2/11/27Mark Edwards, MD, PhD (King’s College London)Functional movement disorders
2/18/27Steve Wu, MD / Don Gilbert, MD (Cincinnati Children’s)Case presentation
2/25/27Manju Kurian, MD, PhD (Great Ormond Street Hospital)Overview of neurotransmitter disorders
3/4/27Jenny Wilson, MD (Oregon Health & Science University)Neurodegeneration with brain iron accumulation disorders
3/11/27Laura Tochen (Children’s National)Case presentation
3/25/27Dan Lumsden, MRCPCH (Evelina London Children’s Hospital)Palliative care in movement disorders
4/1/27Zainab Zaman, MD (BCH)Botox in pediatric movement disorder practice
4/22/27Rebecca Lindsay, MD (BCH Fellow)Fellow case presentation
4/29/27Darius Ebrahimi-Fakhari, MD, PhD (BCH)Hereditary spastic paraplegias
5/6/27Wes Northam, MD (BCH)An approach to surgical management of spasticity
5/13/27Speaker TBD (SickKids Fellow)Fellow case presentation
5/20/27Leon Dure, MD (Children’s of Alabama)Movement disorders in juvenile Huntington’s disease
5/27/27Anne Koy, MD (Universitätsklinikum Köln)DBS in cerebral palsy and acquired dystonias
6/3/27Speaker TBD (CHOP)Case presentation
6/10/27Jennifer Vermillion, MD (University of Rochester)Intersection of psychiatry and movement disorders
6/17/27Haya Alfaris, MD (King Faisal Specialist Hospital and Research)Cases presentations from a tertiary centre in Saudi Arabia
6/24/27Steve Wu, MD / Don Gilbert, MD (Cincinnati Children’s)Case presentation

2025-2026 season talks:

Below is the schedule for the previous season:

DBSMatchmaker

An Innovative Platform for Global Collaboration in Pediatric Movement Disorders

The Challenge

Rare genetic movement disorders are complex and often affect children, presenting significant clinical challenges. Many conditions are ultra-rare, affecting fewer than 100 individuals worldwide. While DBS has shown promising results across an expanding range of monogenic conditions, clinicians often lack comprehensive insights due to limited experience with these rare disorders.

How DBSMatchMaker Works

  1. Submit Cases: Clinicians submit DBS cases through our secure REDCap platform, including genetic and treatment details.
  2. Find Matches: Our team reviews submissions and connects centers treating similar genetic conditions.
  3. Collaborate: Connected centers share experiences and insights to optimize treatment approaches.
DBSMatchmaker Workflow

Join Our Network

Are you a clinician treating rare diseases with DBS? Join our network now:
Access DBSMatchMaker Portal

Contact

For more information about DBSMatchMaker, please contact:
movementdisorders@childrens.harvard.edu

Supporting the Rare Disease Community

We believe that the work of our laboratory should not only be confined to advancing science, but that we should also strive to engage the broader community. Through a variety of outreach efforts, we believe that we can help make our scientific communities more inclusive and learn from the diverse perspectives these experiences provide.